SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0000950123-01-507382
Filing Date
2001-10-19
Accepted
2001-10-19 00:00:00
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-4 y52200a2s-4a.txt S-4/A 1508039
3 SPECIMEN OF COMMON STOCK y52200a2ex4-1.txt EX-4.1 5021
4 EXECUTIVE BONUS PLAN y52200a2ex10-6.txt EX-10.6 16289
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP y52200a2ex23-1.txt EX-23.1 1137
6 CONSENT OF ARTHUR ANDERSEN LLP y52200a2ex23-2.txt EX-23.2 695
7 CONSENT OF ERNST & YOUNG LLP y52200a2ex23-3.txt EX-23.3 748
8 CONSENT OF ARTHUR ANDERSEN LLP y52200a2ex23-4.txt EX-23.4 584
9 CONSENT OF PRICEWATERHOUSECOOPERS LLP y52200a2ex23-5.txt EX-23.5 697
10 CONSENT OF ARTHUR ANDERSEN LLP y52200a2ex23-6.txt EX-23.6 528
  Complete submission text file 0000950123-01-507382.txt   1535885
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

IRS No.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-67392 | Film No.: 1761940
SIC: 2835 In Vitro & In Vivo Diagnostic Substances